{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:11:34Z","timestamp":1782407494025,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bioorg.2023.106657","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T19:29:14Z","timestamp":1686166154000},"page":"106657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A combined network pharmacology and molecular biology approach to investigate the potential mechanisms of G-M6 on ovarian cancer"],"prefix":"10.1016","volume":"138","author":[{"given":"Meng","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xude","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106657_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.bioorg.2023.106657_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.bioorg.2023.106657_b0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic acids research."},{"key":"10.1016\/j.bioorg.2023.106657_b0020","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1038\/onc.2014.314","article-title":"Mechanism-based cancer therapy: resistance to therapy, therapy for resistance","volume":"34","author":"Ramos","year":"2015","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106657_b0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00432-014-1765-5","article-title":"Oncogenes associated with drug resistance in ovarian cancer","volume":"141","author":"Liu","year":"2015","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.bioorg.2023.106657_b0030","first-page":"1","article-title":"Phytochemical Investigation of Antimicrobial and Antioxidant Activity Leaves Extracts of Corchorus olitorius","volume":"3","author":"Mohammed","year":"2016","journal-title":"Open Access library Journal."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106657_b0035","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00044-010-9476-1","article-title":"Immunosuppressive Activity of Hexane and Ethanolic Extracts of Pterospermum Acerifolium Seeds in BALB\/c Mice","volume":"20","author":"Pathak","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.01614","article-title":"Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice","volume":"10","author":"Choudhari","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106657_b0045","first-page":"288","article-title":"Chemical constituents of the hydrolysate of saponins from the basal part of stem of Panax notoginseng","volume":"18","author":"Wang","year":"2008","journal-title":"Chin. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106657_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00280-006-0300-z","article-title":"In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng","volume":"59","author":"Wang","year":"2007","journal-title":"Cancer Chem. Pharm."},{"key":"10.1016\/j.bioorg.2023.106657_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102961","article-title":"New perspective on the metabolism of AD-1 in vivo: Characterization of a series of dammarane-type derivatives with novel metabolic sites and anticancer mechanisms of active oleanane-type metabolites","volume":"88","author":"Ding","year":"2019","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2023.106657_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131016","article-title":"Simultaneous quantification and ADME prediction of AD-1 and its eight metabolites in rat feces, and screening of PARP-1 inhibitors through molecular docking","volume":"1244","author":"Ding","year":"2021","journal-title":"J Mol Struct."},{"key":"10.1016\/j.bioorg.2023.106657_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional chinese medicine: review and assessment","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106657_b0070","doi-asserted-by":"crossref","unstructured":"D. Gfeller, O. Michielin, V. Zoete. Shaping the interaction landscape of bioactive Molecules, Oxford Academic. Bioinformatics. 29. (2013). 3073-3079. 10.1093\/bioinformatics\/btt540.","DOI":"10.1093\/bioinformatics\/btt540"},{"key":"10.1016\/j.bioorg.2023.106657_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/nar\/gkr981","article-title":"Reorganizing the protein space at the Universal Protein Resource (UniProt)","volume":"40","author":"Uniprot","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0080","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database, Oxford Academic","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0095","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bioorg.2023.106657_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank, Oxford Academic","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106657_b0110","first-page":"1","article-title":"Study on the multitarget mechanism and key active ingredients of herba siegesbeckiae and volatile oil against rheumatoid arthritis based on network pharmacology","volume":"11","author":"Yang","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.bioorg.2023.106657_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115992","article-title":"A network pharmacology-integrated metabolomics strategy for clarifying the action mechanisms of Schisandrae Chinensis Fructus for treating drug-induced liver injury by acetaminophen","volume":"31","author":"Li","year":"2021","journal-title":"Bioorgan Med Chem."},{"key":"10.1016\/j.bioorg.2023.106657_b0120","first-page":"255","article-title":"PARP inhibitors and the evolving landscape of ovarian cancer management: a review","volume":"33","author":"Cook","year":"2019","journal-title":"Bio Drugs."},{"key":"10.1016\/j.bioorg.2023.106657_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","article-title":"Ovarian cancer stem cells more questions than answers","volume":"44","author":"Ottevanger","year":"2017","journal-title":"Semin Cancer Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106657_b0130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737140.2017.1398088","article-title":"el al., Optimizing treatment in recurrent epithelial ovarian cancer","volume":"17","author":"Corrado","year":"2017","journal-title":"Expert Rev Anticancer Ther."},{"key":"10.1016\/j.bioorg.2023.106657_b0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3904\/kjim.2017.008","article-title":"Targeted therapy of ovarian cancer including immune check point inhibitor","volume":"32","author":"Kim","year":"2017","journal-title":"Korean J Intern Med."},{"key":"10.1016\/j.bioorg.2023.106657_b0140","doi-asserted-by":"crossref","first-page":"30131","DOI":"10.1074\/jbc.273.46.30131","article-title":"Estrogen-induced production of a peroxisome proliferators-activated receptor (PPAR) ligand in a PPAR gamma-expressing tissue","volume":"273","author":"Ma","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bioorg.2023.106657_b0145","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bjps.2009.06.032","article-title":"Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts","volume":"63","author":"Zhang","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"10.1016\/j.bioorg.2023.106657_b0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjc.6602009","article-title":"Clinical implications of expression of cyclooxygenase-2 and peroxisome proliferators activated-receptor in epithelial ovarian tumors, Brit","volume":"91","author":"Sakamoto","year":"2004","journal-title":"J Cancer."},{"key":"10.1016\/j.bioorg.2023.106657_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111855","article-title":"Zuogui Pills inhibit mitochondria-dependent apoptosis of follicles in a rat model of premature ovarian failure","volume":"238","author":"Peng","year":"2019","journal-title":"J Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2023.106657_b0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbrc.2020.03.139","article-title":"EMT-inducing transcription factor ZEB1-associated resistance to the BCL-2\/BCL-XL inhibitor is overcome by BIM upregulation in ovarian clear cell carcinoma cells","volume":"526","author":"Akane","year":"2020","journal-title":"Biochem Bioph Res Co."},{"key":"10.1016\/j.bioorg.2023.106657_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biochi.2015.01.013","article-title":"Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2\/Bcl-XL expression","volume":"113","author":"Yan","year":"2015","journal-title":"Biochimie."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:52:35Z","timestamp":1758617555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823003188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"alternative-id":["S0045206823003188"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106657","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combined network pharmacology and molecular biology approach to investigate the potential mechanisms of G-M6 on ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106657"}}